[1] |
薄艳秋. 系统性红斑狼疮患者外周血淋巴细胞亚群检测分析. 中国卫生标准管理, 2017, 8(21): 107-109. doi: 10.3969/j.issn.1674-9316.2017.21.057.
doi: 10.3969/j.issn.1674-9316.2017.21.057
|
[2] |
中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南. 中华内科杂志, 2020, 59(3): 172-185. doi: 10.3760/cma.j.issn.0578-1426.2020.03.002.
doi: 10.3760/cma.j.issn.0578-1426.2020.03.002
|
[3] |
翟志芳, 钟华, 郝飞. 系统性红斑狼疮与结核. 中华风湿病学杂志, 2014, 18(3): 207-209. doi: 10.3760/cma.j.issn.1007-7480.2014.03.016.
doi: 10.3760/cma.j.issn.1007-7480.2014.03.016
|
[4] |
孙欣, 徐莉莉, 邓艳红, 等. 系统性红斑狼疮并发感染危险因素的meta分析. 中华护理杂志, 2015, 50(7): 828-835. doi: 10.3761/j.issn.0254-1769.2015.07.013.
doi: 10.3761/j.issn.0254-1769.2015.07.013
|
[5] |
蒲渝成, 廖家吉, 杨晓辉. T淋巴细胞亚群检测在诊断肺结核中的应用价值. 当代医药论丛, 2021, 19(15): 133-135. doi: 10.3969/j.issn.2095-7629.2021.15.075.
doi: 10.3969/j.issn.2095-7629.2021.15.075
|
[6] |
Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum, 2012, 64(8): 2677-2686. doi: 10.1002/art.34473.
doi: 10.1002/art.34473
URL
|
[7] |
Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol, 2002, 29(2): 288-291.
doi: 10.1093/rheumatology/29.4.288
URL
|
[8] |
中华人民共和国国家卫生和计划生育委员会. WS 288-2017 肺结核诊断.2017-11-09.
|
[9] |
Ahmmed MF, Islam MN, Ferdous S, et al. Tuberculosis in Systemic Lupus Erythematosus Patients. Mymensingh Med J, 2019, 28(4): 797-807.
pmid: 31599243
|
[10] |
詹钟平, 劳敏曦, 苏凡, 等. 系统性红斑狼疮合并结核的临床特征和相关因素分析. 实用医学杂志, 2017, 33(21): 3552-3555. doi: 10.3969/j.issn.1006-5725.2017.21.013.
doi: 10.3969/j.issn.1006-5725.2017.21.013
|
[11] |
Lu Z, Li J, Ji J, et al. Altered peripheral lymphocyte subsets in untreated systemic lupus erythematosus patients with infections. Braz J Med Biol Res, 2019, 52(4): e8131. doi: 10.1590/1414-431X20198131.
doi: 10.1590/1414-431X20198131
URL
|
[12] |
秦岭, 邱志锋, 谢静, 等. 系统性红斑狼疮合并机会性感染的疾病谱及其外周血淋巴细胞亚群特点分析. 中华内科杂志, 2018, 57(1): 32-36. doi: 10.3760/cma.j.issn.0578-1426.2018.01.006.
doi: 10.3760/cma.j.issn.0578-1426.2018.01.006
|
[13] |
李海剑, 刘慧, 陶雅非, 等. 系统性红斑狼疮继发感染患者淋巴细胞亚群及CD64指数的检测意义分析. 中华医院感染学杂志, 2016, 26(24): 5619-5621. doi: 10.11816/cn.ni.2016-162209.
doi: 10.11816/cn.ni.2016-162209
|
[14] |
Comte D, Karampetsou MP, Yoshida N, et al. Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus. Arthritis Rheumatol, 2017, 69(5): 1035-1044. doi: 10.1002/art.40038.
doi: 10.1002/art.40038
URL
|
[15] |
Chen PM, Tsokos GC. The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: an update. Curr Opin Rheumatol, 2021, 33(6): 586-591. doi: 10.1097/BOR.0000000000000815.
doi: 10.1097/BOR.0000000000000815
URL
|
[16] |
Li K, Ran R, Jiang Z, et al. Changes in T-lymphocyte subsets and risk factors in human immunodeficiency virus-negative patients with active tuberculosis. Infection, 2020, 48(4): 585-595. doi: 10.1007/s15010-020-01451-2.
doi: 10.1007/s15010-020-01451-2
URL
|